Q4 2023 Design Therapeutics Inc Earnings Call Transcript
And welcome to design's conference call at this time. All participants are in a listen only. There will be a question and answer session after that prepared be advised that this call is being recorded at the company's request. I would now like to turn the call over to Dr. Sean Jeffries, Chief Operating Officer of design Therapeutics.
Yes, welcome, and thank you for joining us today. Earlier we issued a press release outlining our fourth quarter and full year 2023 financial results and updates across our portfolio of gene tech, small molecule genomic medicines. The slides that we'll be using today during today's call will be available along with the recording of this call in the Investors section of our website at design team. I'm Sean Jefferies, Chief Operating Officer of design; and I'm joined today on the call by our Chairman and CEO, Dr. Pratik Shah.
During this call, we will use forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |